Form D · Other Technology
Mendel Health Inc.
San Jose, CA · CIK 0001859170
Offering snapshot reported Mar 30, 2022 · SEC filing
- Reported sold
- $40M Offering amount: $40M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 16, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 30, 2022 | Initial | $40,000,000 | No comparison | 3 | SEC filing |
| Jun 23, 2021 | Initial | $12,681,920 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-439538
Source: Form D, filed Mar 30, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| William B. Deitch | Director |
| Nichola Eliovits | Director |
| Karim Galil | Director, Executive |
| Kyle Lui | Director |
| Wael Salloum | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
111 W St John St., Suite 950
San Jose, CA, 95113
San Jose, CA, 95113